UK markets closed
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • FTSE 250

    20,910.37
    -287.75 (-1.36%)
     
  • AIM

    1,183.25
    -8.61 (-0.72%)
     
  • GBP/EUR

    1.1537
    +0.0039 (+0.34%)
     
  • GBP/USD

    1.3921
    -0.0091 (-0.65%)
     
  • BTC-GBP

    34,173.66
    +479.93 (+1.42%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • DOW

    30,932.37
    -469.64 (-1.50%)
     
  • CRUDE OIL

    61.66
    -1.87 (-2.94%)
     
  • GOLD FUTURES

    1,733.00
    -42.40 (-2.39%)
     
  • NIKKEI 225

    28,966.01
    -1,202.26 (-3.99%)
     
  • HANG SENG

    28,980.21
    -1,093.96 (-3.64%)
     
  • DAX

    13,786.29
    -93.04 (-0.67%)
     
  • CAC 40

    5,703.22
    -80.67 (-1.39%)
     

South and Central American Typhoid Fever Vaccines Market Forecast to 2027 - Market Forecast to Reach US$ 24.37 Million in 2027

Research and Markets
·3-min read

Dublin, Feb. 18, 2021 (GLOBE NEWSWIRE) -- The "South and Central America Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Vaccine Type and Route of administration and Country" report has been added to ResearchAndMarkets.com's offering.

The South and Central America typhoid fever vaccines market is projected to reach US$ 24.37 million in 2027 from US$ 13.79 million. The market is estimated to grow at CAGR of 7.7% from 2020 to 2027. The report highlights trends prevailing in the South and Central America typhoid fever vaccines market and the factors driving the market along with those that act as hindrances.

The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.

The South and Central American typhoid fever vaccines market is expected to grow owing to key prevalence of typhoid in the region, and poor sanitation facilities. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.

The report segments South and Central America Typhoid Fever Vaccines market as follows:

By Vaccine Type

  • Live Attenuated Vaccine

  • Capsular Polysaccharide Vaccines

  • Conjugate Vaccine

  • Others

By Route of Administration

  • Oral

  • Injectable

By Country

  • Brazil

  • Argentina

  • Rest of South and Central America


Key Topics Covered:

1. Introduction

2. South and Central America (SCAM) Typhoid Fever Vaccines Market - Key Takeaways

3. Research Methodology

4. South and Central America (SCAM) Typhoid Fever Vaccines Market Landscape

5. South and Central America (SCAM) Typhoid Fever Vaccines Market Key Market Dynamics

6. Typhoid Fever Vaccines Market - South and Central America (SCAM) Analysis

7. Typhoid Fever Vaccines Market - by Vaccine Type

8. Typhoid Fever Vaccines Market Analysis - by Route of Administration

9. Typhoid Fever Vaccines Market Revenue and Forecasts to 2027 - Geographical Analysis

10. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines Market

11. Company Profiles

12. Appendix

Companies Mentioned

  • GlaxoSmithKline plc

  • Shanghai institute of biological products co. ltd.

  • Sanofi

  • Pax Vax Inc

  • BHARAT BIOTECH

For more information about this report visit https://www.researchandmarkets.com/r/f0ry3s

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900